Bringing clarity or confusion? The role of prostate-specific membrane antigen positron-emission/computed tomography for primary staging in prostate cancer

Declan G Murphy^{1

2}, Michael Hofman³, Nathan Lawrentschuk^{1

4}, Tobias Maurer⁵

Affiliations

¹ Division of Cancer Surgery, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Vic., Australia.
² Epworth Prostate Centre, Epworth Hospital, Melbourne, Vic., Australia.
³ Department of Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Vic., Australia.
⁴ Department of Surgery, The Austin Hospital, University of Melbourne, Heidelberg, Vic., Australia.
⁵ Department of Urology, Technische Universitat Munchen, Klinikum rechts der Isar, Munich, Germany.

Editorial

Declan G Murphy et al. BJU Int. 2017 Feb.

. 2017 Feb;119(2):194-195.

doi: 10.1111/bju.13600.

Declan G Murphy^{1

2}, Michael Hofman³, Nathan Lawrentschuk^{1

4}, Tobias Maurer⁵

¹ Division of Cancer Surgery, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Vic., Australia.
² Epworth Prostate Centre, Epworth Hospital, Melbourne, Vic., Australia.
³ Department of Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Vic., Australia.
⁴ Department of Surgery, The Austin Hospital, University of Melbourne, Heidelberg, Vic., Australia.
⁵ Department of Urology, Technische Universitat Munchen, Klinikum rechts der Isar, Munich, Germany.

No abstract available

Comment on

Prospective evaluation of 68Gallium-prostate-specific membrane antigen positron emission tomography/computed tomography for preoperative lymph node staging in prostate cancer.
van Leeuwen PJ, Emmett L, Ho B, Delprado W, Ting F, Nguyen Q, Stricker PD. van Leeuwen PJ, et al. BJU Int. 2017 Feb;119(2):209-215. doi: 10.1111/bju.13540. Epub 2016 Jun 18. BJU Int. 2017. PMID: 27207581